Literature DB >> 22789544

Innate neural stem cell heterogeneity determines the patterning of glioma formation in children.

Da Yong Lee1, Scott M Gianino, David H Gutmann.   

Abstract

The concept that gliomas comprise a heterogeneous group of diseases distinguished by their developmental origin raises the intriguing possibility that neural stem cells (NSCs) from different germinal zones have differential capacities to respond to glioma-causing genetic changes. We demonstrate that lateral ventricle subventricular zone NSCs are molecularly and functionally distinct from those of the third ventricle. Consistent with a unique origin for pediatric low-grade glioma, third ventricle, but not lateral ventricle, NSCs hyperproliferate in response to mutations characteristic of childhood glioma. Finally, we demonstrate that pediatric optic gliomas in Nf1 genetically engineered mice arise from the third ventricle. Collectively, these observations establish the importance of innate brain region NSC heterogeneity in the patterning of gliomagenesis in children and adults.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22789544      PMCID: PMC3396885          DOI: 10.1016/j.ccr.2012.05.036

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  37 in total

1.  Neurogenesis in the ependymal layer of the adult rat 3rd ventricle.

Authors:  Yi Xu; Nobuaki Tamamaki; Toru Noda; Kazushi Kimura; Yutaka Itokazu; Naoya Matsumoto; Mari Dezawa; Chizuka Ide
Journal:  Exp Neurol       Date:  2005-04       Impact factor: 5.330

2.  hGFAP-cre transgenic mice for manipulation of glial and neuronal function in vivo.

Authors:  L Zhuo; M Theis; I Alvarez-Maya; M Brenner; K Willecke; A Messing
Journal:  Genesis       Date:  2001-10       Impact factor: 2.487

3.  Multipotent CNS stem cells are present in the adult mammalian spinal cord and ventricular neuroaxis.

Authors:  S Weiss; C Dunne; J Hewson; C Wohl; M Wheatley; A C Peterson; B A Reynolds
Journal:  J Neurosci       Date:  1996-12-01       Impact factor: 6.167

4.  Focal ventricular origin and migration of oligodendrocyte precursors into the chick optic nerve.

Authors:  K Ono; Y Yasui; U Rutishauser; R H Miller
Journal:  Neuron       Date:  1997-08       Impact factor: 17.173

5.  Glial progenitors in the brainstem give rise to malignant gliomas by platelet-derived growth factor stimulation.

Authors:  Kenta Masui; Satoshi O Suzuki; Rina Torisu; James E Goldman; Peter Canoll; Toru Iwaki
Journal:  Glia       Date:  2010-07       Impact factor: 7.452

6.  High frequency of TP53 mutations in juvenile pilocytic astrocytomas indicates role of TP53 in the development of these tumors.

Authors:  V M Hayes; C M Dirven; A Dam; E Verlind; W M Molenaar; J J Mooij; R M Hofstra; C H Buys
Journal:  Brain Pathol       Date:  1999-07       Impact factor: 6.508

7.  Radial glia cells are candidate stem cells of ependymoma.

Authors:  Michael D Taylor; Helen Poppleton; Christine Fuller; Xiaoping Su; Yongxing Liu; Patricia Jensen; Susan Magdaleno; James Dalton; Christopher Calabrese; Julian Board; Tobey Macdonald; Jim Rutka; Abhijit Guha; Amar Gajjar; Tom Curran; Richard J Gilbertson
Journal:  Cancer Cell       Date:  2005-10       Impact factor: 31.743

8.  Combinations of genetic mutations in the adult neural stem cell compartment determine brain tumour phenotypes.

Authors:  Thomas S Jacques; Alexander Swales; Monika J Brzozowski; Nico V Henriquez; Jacqueline M Linehan; Zaman Mirzadeh; Catherine O' Malley; Heike Naumann; Arturo Alvarez-Buylla; Sebastian Brandner
Journal:  EMBO J       Date:  2009-11-19       Impact factor: 11.598

9.  Optic nerve glioma in mice requires astrocyte Nf1 gene inactivation and Nf1 brain heterozygosity.

Authors:  M Livia Bajenaru; M Rosario Hernandez; Arie Perry; Yuan Zhu; Luis F Parada; Joel R Garbow; David H Gutmann
Journal:  Cancer Res       Date:  2003-12-15       Impact factor: 12.701

10.  Identification of human brain tumour initiating cells.

Authors:  Sheila K Singh; Cynthia Hawkins; Ian D Clarke; Jeremy A Squire; Jane Bayani; Takuichiro Hide; R Mark Henkelman; Michael D Cusimano; Peter B Dirks
Journal:  Nature       Date:  2004-11-18       Impact factor: 49.962

View more
  59 in total

Review 1.  A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor.

Authors:  Nancy Ratner; Shyra J Miller
Journal:  Nat Rev Cancer       Date:  2015-04-16       Impact factor: 60.716

2.  Oncogenic KRAS promotes malignant brain tumors in zebrafish.

Authors:  Bensheng Ju; Wenbiao Chen; Brent A Orr; Jan M Spitsbergen; Sujuan Jia; Christopher J Eden; Hannah E Henson; Michael R Taylor
Journal:  Mol Cancer       Date:  2015-02-03       Impact factor: 27.401

3.  The NSL Chromatin-Modifying Complex Subunit KANSL2 Regulates Cancer Stem-like Properties in Glioblastoma That Contribute to Tumorigenesis.

Authors:  Nazarena E Ferreyra Solari; Fiorella S Belforte; Lucía Canedo; Guillermo A Videla-Richardson; Joaquín M Espinosa; Mario Rossi; Eva Serna; Miguel A Riudavets; Horacio Martinetto; Gustavo Sevlever; Carolina Perez-Castro
Journal:  Cancer Res       Date:  2016-07-12       Impact factor: 12.701

Review 4.  Neurofibromatosis type 1: modeling CNS dysfunction.

Authors:  David H Gutmann; Luis F Parada; Alcino J Silva; Nancy Ratner
Journal:  J Neurosci       Date:  2012-10-10       Impact factor: 6.167

5.  A murine model of neurofibromatosis type 2 that accurately phenocopies human schwannoma formation.

Authors:  Jeffrey R Gehlhausen; Su-Jung Park; Ann E Hickox; Matthew Shew; Karl Staser; Steven D Rhodes; Keshav Menon; Jacquelyn D Lajiness; Muithi Mwanthi; Xianlin Yang; Jin Yuan; Paul Territo; Gary Hutchins; Grzegorz Nalepa; Feng-Chun Yang; Simon J Conway; Michael G Heinz; Anat Stemmer-Rachamimov; Charles W Yates; D Wade Clapp
Journal:  Hum Mol Genet       Date:  2014-08-11       Impact factor: 6.150

Review 6.  Optimizing biologically targeted clinical trials for neurofibromatosis.

Authors:  David H Gutmann; Jaishri O Blakeley; Bruce R Korf; Roger J Packer
Journal:  Expert Opin Investig Drugs       Date:  2013-02-21       Impact factor: 6.206

7.  Inhibitory activities of trichostatin a in U87 glioblastoma cells and tumorsphere-derived cells.

Authors:  Felipe de Almeida Sassi; Lílian Caesar; Mariane Jaeger; Carolina Nör; Ana Lucia Abujamra; Gilberto Schwartsmann; Caroline Brunetto de Farias; Algemir Lunardi Brunetto; Patrícia Luciana da Costa Lopez; Rafael Roesler
Journal:  J Mol Neurosci       Date:  2014-01-25       Impact factor: 3.444

8.  Pediatric glioma-associated KIAA1549:BRAF expression regulates neuroglial cell growth in a cell type-specific and mTOR-dependent manner.

Authors:  Aparna Kaul; Yi-Hsien Chen; Ryan J Emnett; Sonika Dahiya; David H Gutmann
Journal:  Genes Dev       Date:  2012-11-14       Impact factor: 11.361

9.  NG2-cells are not the cell of origin for murine neurofibromatosis-1 (Nf1) optic glioma.

Authors:  A C Solga; S M Gianino; D H Gutmann
Journal:  Oncogene       Date:  2013-01-14       Impact factor: 9.867

10.  Temporal, spatial, and genetic constraints contribute to the patterning and penetrance of murine neurofibromatosis-1 optic glioma.

Authors:  Nicole M Brossier; Sharanya Thondapu; Olivia M Cobb; Sonika Dahiya; David H Gutmann
Journal:  Neuro Oncol       Date:  2021-04-12       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.